Oxfordshire Clinical Commissioning Group Formulary

	Oxfordshire Clinical Commissioning Group
	Formulary

Search

Formulary Chapter 4: Central nervous system - Full Chapter

Chapter Links...

OCCG Guidelines: Primary Care Generalised Anxiety Disorder Guideline for Adults and Older Adults

Details...

04.07.04.01

Treatment of the acute migraine attack

OCCG Guidelines: Migraine in Pregnancy and Breastfeeding

OCCG Guidelines: Migraines - acute therapy guidelines (adults)

04.07.04.01

Analgesics

04.07.04.01

5HT1 agonists

Sumatriptan
(Oral)

First Choice

First line triptan for treatment of acute migraine, in line with Migraine: Acute Therapy Guidelines (Adult).

NB. RADIS formulation is BLACK listed locally.

APCO November 2016.

Zolmitriptan
(Oral)

First Choice

First line triptan for treatment of acute migraine, in line with Migraine: Acute Therapy Guidelines (Adult).

APCO November 2016.

Naratriptan (Naramig^®)

Second Choice

For treatment of acute migraine if unaccetable side effects with first-line triptans and for recurrent migraine, in line with Migraine: Acute Therapy Guidelines (Adult).

APCO November 2016.

Almotriptan (Almogran^®)

Second Choice

For treatment of acute migraine if unaccetable side effects with first-line triptans, in line with Migraine: Acute Therapy Guidelines (Adult).

APCO November 2016.

Eletriptan (Relpax^®)

Second Choice

For treatment of acute migraine if unaccetable side effects with first-line triptans and for recurrent migraine, in line with Migraine: Acute Therapy Guidelines (Adult).

APCO November 2016.

Frovatriptan

Formulary

For recurrent migraine in line with Migraine: Acute Therapy Guidelines (Adult).

APCO November 2016.

Sumatriptan (Imigran Subject^® )
(Pre-filled injection)

Restricted

For treatment of acute migraine if vomiting, in line with Migraine: Acute Therapy Guidelines (Adult).

APCO November 2016.

Zolmitriptan (Zomig^®)
(Nasal spray)

Restricted

For treatment of acute migraine if vomiting, in line with Migraine: Acute Therapy Guidelines (Adult).

APCO November 2016.

04.07.04.01

Ergot alkaloids

04.07.04.01

Anti-emetics

04.07.04.01

Other drugs for migrane

....

Non Formulary Items

Rizatriptan (Maxalt^®)

Non Formulary

Not included in line with Migraine: Acute Therapy Guidelines (Adult).

Sumatriptan (Imigran^® Radis)

Non Formulary

Not recommended for use, refer to Migraine: Acute Therapy Guidelines (Adult).

APCO September 2015.

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to children's BNF
	Link to SPCs
	Scottish Medicines Consortium

	Cytotoxic Drug
	Controlled Drug
	High Cost Medicine
	Cancer Drugs Fund
	NHS England
	Homecare
	CCG

Traffic Light Status Information

Status	Description
	Red: Medicines which should only be prescribed in secondary care by a specialist.
	Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.
	Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).
	Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.
	Brown: Medicines which should only be prescribed in restricted circumstances.
	Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.
	not used